On the Versatility of von Willebrand Factor

Von Willebrand factor (VWF) is a large multimeric protein, the function of which has been demonstrated to be pivotal to the haemostatic system. Indeed, quantitative and/or qualitative abnormalities of VWF are associated with the bleeding disorder Von Willebrand disease (VWD). Moreover, increased plasma concentrations of VWF have been linked to an increased risk for thrombotic complications. In the previous decades, many studies have contributed to our understanding of how VWF is connected to the haemostatic system, particularly with regard to structure-function relationships. Interactive sites for important ligands of VWF (such as factor VIII, collagen, glycoprotein Ibα, integrin αIIbβ3 and protease ADAMTS13) have been identified, and mutagenesis studies have confirmed the physiological relevance of the interactions between VWF and these ligands. However, we have also become aware that VWF has a more versatile character than previously thought, given its potential role in various non-hemostatic processes, like intimal thickening, tumor cell apoptosis and inflammatory processes. In the presence review, a summary of our knowledge on VWF structure-function relationships is provided in the context of the “classical” haemostatic task of VWF and in perspective of pathological processes beyond haemostasis.

[1]  J. Gill,et al.  Variability in platelet‐ and collagen‐binding defects in type 2M von Willebrand disease , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  C. Casari,et al.  Clearance of von Willebrand factor , 2013, Journal of thrombosis and haemostasis : JTH.

[3]  M. Overgaard,et al.  An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. , 2013, Thrombosis research.

[4]  P. Kamphuisen,et al.  Reduced prevalence of arterial thrombosis in von Willebrand disease , 2013, Journal of thrombosis and haemostasis : JTH.

[5]  Giuseppe Lippi,et al.  von Willebrand factor and cancer: a renewed interest. , 2013, Thrombosis research.

[6]  M. Franchini,et al.  Von Willebrand disease‐associated angiodysplasia: a few answers, still many questions , 2013, British journal of haematology.

[7]  J. Moake,et al.  Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis , 2013, PloS one.

[8]  C. Casari,et al.  Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the protein. , 2013, Blood.

[9]  R. Ljung,et al.  Factor VIII products and inhibitor development in severe hemophilia A. , 2013, The New England journal of medicine.

[10]  S. D. De Meyer,et al.  Unwinding the von Willebrand factor strings puzzle. , 2013, Blood.

[11]  C. Casari,et al.  Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5 , 2012, Haematologica.

[12]  C. Casari,et al.  von Willebrand factor: the old, the new and the unknown , 2012, Journal of thrombosis and haemostasis : JTH.

[13]  K. Mertens,et al.  Distinct Roles of Ser-764 and Lys-773 at the N Terminus of von Willebrand Factor in Complex Assembly with Coagulation Factor VIII* , 2012, The Journal of Biological Chemistry.

[14]  R. Montgomery,et al.  Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo , 2012, Journal of thrombosis and haemostasis : JTH.

[15]  Qiong Wang,et al.  The unfolded von Willebrand factor response in bloodstream: the self-association perspective , 2012, Journal of Hematology & Oncology.

[16]  C. Casari,et al.  A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor. , 2012, Blood.

[17]  Shannon L Meeks,et al.  A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function. , 2012, Blood.

[18]  R. Schutgens,et al.  Von Willebrand factor deficiency and atherosclerosis. , 2012, Blood reviews.

[19]  D. Wagner,et al.  Neutrophil extracellular trap (NET) impact on deep vein thrombosis. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[20]  D. Motto,et al.  ADAMTS13 reduces VWF‐mediated acute inflammation following focal cerebral ischemia in mice , 2012, Journal of thrombosis and haemostasis : JTH.

[21]  T. Walz,et al.  Sequence and structure relationships within von Willebrand factor. , 2012, Blood.

[22]  D. Bellissimo,et al.  Critical von Willebrand factor A1 domain residues influence type VI collagen binding , 2012, Journal of thrombosis and haemostasis : JTH.

[23]  C. Millar,et al.  Characterisation of von Willebrand factor A1 domain mutants I1416N and I1416T: correlation of clinical phenotype with flow‐based platelet adhesion , 2012, Journal of thrombosis and haemostasis : JTH.

[24]  H. Okano,et al.  Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor. , 2012, Journal of the National Cancer Institute.

[25]  W. Hauswirth,et al.  CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  P. James,et al.  von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies , 2012, American journal of hematology.

[27]  R. Bierings,et al.  Proteomic screen identifies IGFBP7 as a novel component of endothelial cell-specific Weibel-Palade bodies. , 2012, Journal of proteome research.

[28]  P. Lenting,et al.  Current understanding of thrombosis and hemostasis — from bench to bedside von Willebrand factor : at the crossroads of bleeding and thrombosis , 2012 .

[29]  Riyao Yang,et al.  Galectins in acute and chronic inflammation , 2012, Annals of the New York Academy of Sciences.

[30]  P. D. de Groot,et al.  Identification of Galectin-1 and Galectin-3 as Novel Partners for Von Willebrand Factor , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[31]  P. Mannucci,et al.  Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients , 2012, Journal of thrombosis and haemostasis : JTH.

[32]  A. Hofman,et al.  Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam Study , 2012, Journal of thrombosis and haemostasis : JTH.

[33]  E. Huizinga,et al.  Implications for collagen I chain registry from the structure of the collagen von Willebrand factor A3 domain complex , 2012, Proceedings of the National Academy of Sciences.

[34]  A. Chauhan,et al.  ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. , 2012, Blood.

[35]  C. Casari,et al.  Macrophage LRP1 contributes to the clearance of von Willebrand factor. , 2012, Blood.

[36]  N. Gupta,et al.  Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[37]  L. Thompson,et al.  Parotid Gland Solitary Fibrous Tumor: A Case Report and Clinicopathologic Review of 22 Cases from the Literature , 2012, Head and Neck Pathology.

[38]  Michael M. Wang,et al.  von Willebrand Factor Permeates Small Vessels in CADASIL and Inhibits Smooth Muscle Gene Expression , 2012, Translational Stroke Research.

[39]  E. Boerwinkle,et al.  Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study. , 2012, Blood.

[40]  L. Thim,et al.  High Affinity Binding of FVIII to VWF Is Not Required for the Haemostatic Effect of FVIII In Vivo , 2011 .

[41]  T. Walz,et al.  A pH‐regulated dimeric bouquet in the structure of von Willebrand factor , 2011, The EMBO journal.

[42]  D. Lane,et al.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. , 2011, Blood.

[43]  T. Springer,et al.  Biology and physics of von Willebrand factor concatamers , 2011, Journal of thrombosis and haemostasis : JTH.

[44]  R. Schneppenheim,et al.  von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein , 2011, Journal of thrombosis and haemostasis : JTH.

[45]  D. Strachan,et al.  Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. , 2011, Blood.

[46]  A. Hughes,et al.  Endothelial von Willebrand factor regulates angiogenesis. , 2011, Blood.

[47]  C. Denis,et al.  Novel Function of Tenascin-C, a Matrix Protein Relevant to Atherosclerosis, in Platelet Recruitment and Activation Under Flow , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[48]  A. Zarbock,et al.  von Willebrand factor promotes leukocyte extravasation. , 2010, Blood.

[49]  Junmei Chen,et al.  Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region. , 2010, Blood.

[50]  Z. Ruggeri,et al.  Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib , 2010, Thrombosis and Haemostasis.

[51]  G. Stoll,et al.  Binding of von Willebrand Factor to Collagen and Glycoprotein Ib&agr;, But Not to Glycoprotein IIb/IIIa, Contributes to Ischemic Stroke in Mice—Brief Report , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[52]  A. Hofman,et al.  High von Willebrand Factor Levels Increase the Risk of Stroke: The Rotterdam Study , 2010, Stroke.

[53]  G. Lippi,et al.  Von Willebrand factor-containing factor VIII concentrates and inhibitors in haemophilia A , 2010, Thrombosis and Haemostasis.

[54]  M. Slaughter Hematologic Effects of Continuous Flow Left Ventricular Assist Devices , 2010, Journal of cardiovascular translational research.

[55]  P. D. de Groot,et al.  Regulation of von Willebrand factor-platelet interactions , 2010, Thrombosis and Haemostasis.

[56]  F. Rosendaal,et al.  Risk factors for venous thrombosis – current understanding from an epidemiological point of view , 2010, British journal of haematology.

[57]  R. Hoffmann,et al.  Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD , 2010, Journal of thrombosis and haemostasis : JTH.

[58]  A. Goodeve The genetic basis of von Willebrand disease. , 2010, Blood reviews.

[59]  T. Miyata,et al.  ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion. , 2010, Blood.

[60]  C. Ruan,et al.  The glycoprotein Ibα–von Willebrand factor interaction induces platelet apoptosis , 2010, Journal of thrombosis and haemostasis : JTH.

[61]  J. Sadler,et al.  Multi‐step binding of ADAMTS‐13 to von Willebrand factor , 2009, Journal of thrombosis and haemostasis : JTH.

[62]  B. Sorg,et al.  Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. , 2009, The Journal of clinical investigation.

[63]  M. Laffan,et al.  Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor. , 2009, Blood.

[64]  A. Chauhan,et al.  von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. , 2009, Blood.

[65]  P. Lenting,et al.  A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF. , 2009, Blood.

[66]  J. Sadler von Willebrand factor assembly and secretion , 2009, Journal of thrombosis and haemostasis : JTH.

[67]  Cheng-Zhong Zhang,et al.  Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor , 2009, Science.

[68]  M. Jacquemin Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A , 2009, Acta Haematologica.

[69]  E. Willebrand Über hereditäre Pseudohämophilie. , 2009 .

[70]  I. Nilsson,et al.  Von Willebrand's disease and its correction with human plasma fraction 1-0. , 2009, Acta medica Scandinavica.

[71]  R. Kiss,et al.  Galectins and Gliomas , 2009, Brain pathology.

[72]  H. Tsai Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura. , 2009, Kidney international. Supplement.

[73]  Z. Ruggeri,et al.  Platelet Adhesion under Flow , 2009, Microcirculation.

[74]  M. Berndt,et al.  Platelet adhesion: a game of catch and release. , 2008, The Journal of clinical investigation.

[75]  J. Zachary,et al.  von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis. , 2008, The American journal of pathology.

[76]  O. Christophe,et al.  Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa. , 2008, Blood.

[77]  J. Moake,et al.  Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions , 2008, Journal of thrombosis and haemostasis : JTH.

[78]  Y. Ozaki,et al.  Redundant Mechanism of Platelet Adhesion to Laminin and Collagen under Flow , 2008, Journal of Biological Chemistry.

[79]  P. Lenting,et al.  Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13 , 2008, Proceedings of the National Academy of Sciences.

[80]  B. Jilma,et al.  Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes , 2008, Circulation.

[81]  O. Christophe,et al.  Correction of Bleeding Symptoms in von Willebrand Factor–Deficient Mice by Liver-Expressed von Willebrand Factor Mutants , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[82]  A. Chauhan,et al.  Glycoprotein Ibα and von Willebrand factor in primary platelet adhesion and thrombus formation: Lessons from mutant mice , 2008, Thrombosis and Haemostasis.

[83]  J. Goudemand Inhibitor development in haemophilia A: the role of von Willebrand factor/factor VIII concentrates , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[84]  O. Christophe,et al.  Characterization of the interaction between von Willebrand factor and osteoprotegerin , 2007, Journal of thrombosis and haemostasis : JTH.

[85]  P. Lenting,et al.  Clearance mechanisms of von Willebrand factor and factor VIII , 2007, Journal of thrombosis and haemostasis : JTH.

[86]  Z. Ruggeri Von Willebrand factor: Looking back and looking forward , 2007, Thrombosis and Haemostasis.

[87]  G. Auerswald,et al.  Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study. , 2007, Blood.

[88]  S. Kaveri,et al.  A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes , 2007, Proceedings of the National Academy of Sciences.

[89]  A Alexander-Katz,et al.  Shear-induced unfolding triggers adhesion of von Willebrand factor fibers , 2007, Proceedings of the National Academy of Sciences.

[90]  P. Hogg,et al.  Hypothesis for control of von Willebrand factor multimer size by intra‐molecular thiol‐disulphide exchange , 2007, Journal of thrombosis and haemostasis : JTH.

[91]  Sriram Neelamegham,et al.  Solution Structure of Human von Willebrand Factor Studied Using Small Angle Neutron Scattering* , 2006, Journal of Biological Chemistry.

[92]  C. Gahmberg,et al.  P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. , 2006, Blood.

[93]  Richard W Farndale,et al.  A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides. , 2006, Blood.

[94]  A. Chauhan,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins , 2007 .

[95]  R. Romijn,et al.  von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen , 2006, Journal of thrombosis and haemostasis : JTH.

[96]  J. V. van Mourik,et al.  Unraveling the mystery of von Willebrand factor , 2006, Journal of thrombosis and haemostasis : JTH.

[97]  D Meyer,et al.  Increased metastatic potential of tumor cells in von Willebrand factor‐deficient mice , 2006, Journal of thrombosis and haemostasis : JTH.

[98]  M. Crúz,et al.  The interaction of von Willebrand factor‐A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen , 2006, Journal of thrombosis and haemostasis : JTH.

[99]  W. Owen Big piece, little piece or: Yes, factor VIII is a protein , 2005, Journal of thrombosis and haemostasis : JTH.

[100]  A. Zannettino,et al.  Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor , 2005, Journal of cellular physiology.

[101]  J. Moake,et al.  Platelets adhered to endothelial cell‐bound ultra‐large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress , 2005, Journal of thrombosis and haemostasis : JTH.

[102]  P. Mannucci,et al.  Plasma levels of von Willebrand factor regulate ADAMTS‐13, its major cleaving protease , 2004, British journal of haematology.

[103]  L. Mosyak,et al.  Crystal Structure of the Wild-type von Willebrand Factor A1-Glycoprotein Ibα Complex Reveals Conformation Differences with a Complex Bearing von Willebrand Disease Mutations* , 2004, Journal of Biological Chemistry.

[104]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[105]  D. Arveiler,et al.  Endothelial Cell Markers and the Risk of Coronary Heart Disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study , 2004, Circulation.

[106]  S. Susen,et al.  Acquired von Willebrand syndrome in aortic stenosis. , 2003, The New England journal of medicine.

[107]  S. Watson,et al.  Platelet-collagen interaction: is GPVI the central receptor? , 2003, Blood.

[108]  J. Sixma,et al.  Mapping the Collagen-binding Site in the von Willebrand Factor-A3 Domain* , 2003, The Journal of Biological Chemistry.

[109]  H. Dardik,et al.  Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies. , 2003, Journal of vascular surgery.

[110]  A. Folsom,et al.  Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). , 2002, The American journal of medicine.

[111]  J. Danesh,et al.  von Willebrand factor and coronary heart disease: prospective study and meta-analysis. , 2002, European heart journal.

[112]  J. Sixma,et al.  Structures of Glycoprotein Ibα and Its Complex with von Willebrand Factor A1 Domain , 2002, Science.

[113]  J. Saint-Remy,et al.  Von Willebrand Factor Modulates Factor VIII Immunogenicity: Comparative Study of Different Factor VIII Concentrates in a Haemophilia A Mouse Model , 2002, Thrombosis and Haemostasis.

[114]  H. Deckmyn,et al.  Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. , 2002, Blood.

[115]  T. Foroud,et al.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura , 2001, Nature.

[116]  J. Lavergne,et al.  Ser968Thr Mutation within the A3 Domain of Von Willebrand Factor (VWF) in Two Related Patients Leads to a Defective Binding of VWF to Collagen , 2001, Thrombosis and Haemostasis.

[117]  D. Wagner,et al.  Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. , 2001, Blood.

[118]  M. Massot,et al.  Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[119]  P. Hogg,et al.  Control of Von Willebrand Factor Multimer Size by Thrombospondin-1 , 2001, The Journal of experimental medicine.

[120]  C. Denis,et al.  Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[121]  G. D. De Meyer,et al.  Intimal deposition of functional von Willebrand factor in atherogenesis. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[122]  J. V. van Mourik,et al.  The Light Chain of Factor VIII Comprises a Binding Site for Low Density Lipoprotein Receptor-related Protein* , 1999, The Journal of Biological Chemistry.

[123]  A. Folsom,et al.  Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1999, Circulation.

[124]  José A López,et al.  The Glycoprotein Ib-IX-V Complex in Platelet Adhesion and Signaling , 1999, Thrombosis and Haemostasis.

[125]  G. E. Gilbert,et al.  Collagen-bound von Willebrand Factor Has Reduced Affinity for Factor VIII* , 1999, The Journal of Biological Chemistry.

[126]  J. Vermylen,et al.  A New Animal Model of Thrombophilia Confirms that High Plasma Factor VIII Levels Are Thrombogenic , 1999, Thrombosis and Haemostasis.

[127]  H. Tsai,et al.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. , 1998, The New England journal of medicine.

[128]  B. Lämmle,et al.  von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. , 1998 .

[129]  R. Hynes,et al.  A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[130]  E. Vicaut,et al.  Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. , 1998, Circulation.

[131]  M. Lewis,et al.  Redistribution of von Willebrand factor in porcine carotid arteries after balloon angioplasty. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[132]  José A López,et al.  Structure and function of the glycoprotein Ib‐IX‐V complex , 1997, Current opinion in hematology.

[133]  E. Saenko,et al.  The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor* , 1997, The Journal of Biological Chemistry.

[134]  J. Sixma,et al.  Platelet Adhesion to Collagen: an Update , 1997, Thrombosis and Haemostasis.

[135]  M. Hoylaerts,et al.  von Willebrand factor binds to native collagen VI primarily via its A1 domain. , 1997, The Biochemical journal.

[136]  C. Vrints,et al.  Fibrin(ogen) and von Willebrand factor deposition are associated with intimal thickening after balloon angioplasty of the rabbit carotid artery. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[137]  K. Amano,et al.  Factor VIII Inhibitor Antibodies with C2 Domain Specificity Are Less inhibitory to Factor VIII Complexed with von Willebrand Factor , 1996, Thrombosis and Haemostasis.

[138]  R. Marchant,et al.  Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. , 1996, Blood.

[139]  J. Sixma,et al.  A3 Domain Is Essential for Interaction of von Willebrand Factor with Collagen Type III , 1996, Thrombosis and Haemostasis.

[140]  K. Amano,et al.  Autoantibody to factor VIII that has less reactivity to factor Vlll/von Willebrand Factor Complex , 1995, American journal of hematology.

[141]  J. Sixma,et al.  Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor. , 1995, Blood.

[142]  R. Handin,et al.  Interaction of the von Willebrand Factor (vWF) with Collagen , 1995, The Journal of Biological Chemistry.

[143]  S. Thompson,et al.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.

[144]  J. Vandenbroucke,et al.  Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.

[145]  A. Zaleski,et al.  Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. , 1994, The Journal of laboratory and clinical medicine.

[146]  P. Lenting,et al.  Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII. , 1994, The Journal of biological chemistry.

[147]  É. Fressinaud,et al.  International Survey of Patients with von Willebrand Disease and Angiodysplasia , 1993, Thrombosis and Haemostasis.

[148]  P. Mannucci,et al.  Pharmacokinetics of Monoclonally-Purified and Recombinant Factor VIII in Patients with Severe von Willebrand Disease , 1993, Thrombosis and Haemostasis.

[149]  D. Baruch,et al.  Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[150]  D. A. Beacham,et al.  Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis. , 1992, The Journal of biological chemistry.

[151]  J. Sadler von Willebrand factor. , 1991, The Journal of biological chemistry.

[152]  A. Giles,et al.  The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. , 1991, The Journal of biological chemistry.

[153]  P. Fay,et al.  von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. , 1991, The Journal of biological chemistry.

[154]  C. Niehrs,et al.  Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. , 1991, The Journal of biological chemistry.

[155]  D. Tate,et al.  von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. , 1990, Arteriosclerosis.

[156]  J. Sixma,et al.  The effect of von Willebrand factor on activation of factor VIII by factor Xa. , 1990, European journal of biochemistry.

[157]  H. Mohri,et al.  Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites. , 1989, The Journal of biological chemistry.

[158]  C. Rothschild,et al.  New variant of von Willebrand disease with defective binding to factor VIII. , 1989, Blood.

[159]  J. Voorberg,et al.  5 Molecular cloning, expression and assembly of multimeric von Willebrand factor* , 1989 .

[160]  J. V. van Mourik,et al.  The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII. , 1989, The Biochemical journal.

[161]  D. Baruch,et al.  von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein Ib. , 1988, The Journal of laboratory and clinical medicine.

[162]  D. Meyer,et al.  Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. , 1987, Blood.

[163]  J. McPherson,et al.  Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. , 1987, The Journal of biological chemistry.

[164]  K. Titani,et al.  A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. , 1987, The Journal of biological chemistry.

[165]  L. Holland,et al.  Isolation and characterization of a collagen binding domain in human von Willebrand factor. , 1986, The Journal of biological chemistry.

[166]  P. Diergaarde,et al.  Full‐length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. , 1986, The EMBO journal.

[167]  G. Soff,et al.  The von Willebrand Factor in Myocardial Infarction and Unstable Angina: A Kinetic Study , 1986, Thrombosis and Haemostasis.

[168]  R. D. Wade,et al.  Amino acid sequence of human von Willebrand factor. , 1986, Biochemistry.

[169]  K. Titani,et al.  Cloning and characterization of two cDNAs coding for human von Willebrand factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[170]  D. Wagner,et al.  Biosynthesis of von Willebrand protein by human megakaryocytes. , 1985, The Journal of clinical investigation.

[171]  S. Latt,et al.  Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. , 1985, Science.

[172]  C. J. Collins,et al.  Molecular cloning of cDNA for human von willebrand factor: Authentication by a new method , 1985, Cell.

[173]  D. Wagner,et al.  Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain. , 1983, The Journal of biological chemistry.

[174]  E. Tuddenham,et al.  Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease , 1982, British journal of haematology.

[175]  R. Montgomery,et al.  Newborn Factor VIII Complex: Elevated Activities in Term Infants and Alterations in Electrophoretic Mobility Related to Illness and Activated Coagulatio , 1981, British journal of haematology.

[176]  S. Santoro Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens. , 1981, Thrombosis research.

[177]  D. Nyman Interaction of collagen with the factor VIII antigen-activity - von Willebrand factor complex. , 1977, Thrombosis research.

[178]  I. Sussman,et al.  Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. , 1977, The Journal of clinical investigation.

[179]  H. Deckmyn,et al.  Platelet adhesion to collagen. , 2011, Thrombosis research.

[180]  J. Sadler,et al.  Low von Willebrand factor: sometimes a risk factor and sometimes a disease. , 2009, Hematology. American Society of Hematology. Education Program.

[181]  C. Denis,et al.  Role of von Willebrand factor in tumor metastasis. , 2007, Thrombosis research.

[182]  T. Lambert,et al.  Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A. , 2006, Blood.

[183]  N. Shimba,et al.  Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment , 2003, Nature Structural Biology.

[184]  J. Spivak,et al.  Commentary on and reprint of von Willebrand EA, Über hereditäre Pseudohämophilie [On hereditary pseudohemophilia], in Acta Medica Scandinavica (1931) 76:521–549 , 2000 .

[185]  B. Lämmle,et al.  Recovery and Half-Life of von Willebrand Factor-Cleaving Protease after Plasma Therapy in Patients with Thrombotic Thrombocytopenic Purpura , 1999, Thrombosis and Haemostasis.

[186]  F. Cohen,et al.  Biochemistry and genetics of von Willebrand factor. , 1998, Annual review of biochemistry.

[187]  D. Wagner Cell biology of von Willebrand factor. , 1990, Annual review of cell biology.

[188]  J. Voorberg,et al.  Molecular cloning, expression and assembly of multimeric von Willebrand factor. , 1989, Bailliere's clinical haematology.

[189]  I. Sussman,et al.  STUDIES ON POSTTRANSFUSION AND DISSOCIATED FACTOR VIII AND IN PATIENTS WITH VON WILLEBRAND'S DISEASE , 1977 .